循環器臨床サピア　2　最新アプローチ急性冠症候群

出版社： 中山書店
著者：
発行日： 2009-10-01
分野： 臨床医学：内科  >  血管
ISBN： 9784521731629
シリーズ： 循環器臨床サピア
電子書籍版： 2009-10-01 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

13,200 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

13,200 円(税込)

購入する

商品紹介

本症候群は循環器専門医や内科医のみならず医師なら誰でも遭遇するきわめて一般的な疾患であり，初期の対応で患者の予後が決まるため，プライマリ・ケアが重要である。本書では，この急性冠症候群の病態，診断，治療のどの項目も最新の内容をわかりやすく解説。急性冠症候群の理解を深めるための必携書。

目次

  • 循環器臨床サピア　2　最新アプローチ急性冠症候群

    ―目次―

    1章　急性冠症候群の病態を知る
    　概念
    　日本における疫学的知見と治療成績
    　病理
    　発生機序
    　分類---ST上昇型と非ST上昇型

    2章　急性冠症候群を見逃さない
    　ガイドラインに示された診断アプローチ
    　初診時の診断のポイント
    　心電図診断
    　生化学診断
    　急性期超音波診断
    　冠動脈造影の意義
    　コントラストエコー法の有用性
    　血管内超音波診断
    　optical coherence tomography(OCT)
    　血管内視鏡所見
    　不安定プラーク評価におけるマルチスライスCTの意義
    　心筋ダメージの核医学的評価

    3章　急性冠症候群のベストの急性期治療は何か
    　プレホスピタル治療の意義
    　ST上昇型急性心筋梗塞の再灌流治療
    　非ST上昇型急性冠症候群
    　血栓溶解療法
    　primary PCIの適応と効果
    　血栓吸引療法とdistal protectionの効果
    　再潅流障害の対策
    　late reperfusionの適応と効果
    　心原性ショックの治療戦略
    　緊急冠動脈バイパス術の適応
    　急性期の治療体制
    　虚血性心疾患の地域連携パス

    4章　急性冠症候群の再発をいかに防ぐか
    　慢性期の治療指針
    　抗血小板薬の重要性
    　硝酸薬の評価
    　β遮断薬の有用性
    　Ca拮抗薬の使用法
    　スタチン製剤の重要性
    　ACE阻害剤とアンジオテンシンII受容体拮抗薬
    　慢性期のカテーテルインターベンション
    　慢性期の外科治療
    　慢性期の血管新生療法

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章 急性冠症候群の病態を知る

P.7 掲載の参考文献
1) Ogawa H. Pathophysiology of acute coronary syndromes. J Cardiol 1999 ; 33 Suppl 1 : 9-16.
 
2) Alpert JS, et al. Myocardial infarction redefined : A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000 ; 36 : 959-969.
 
3) ISIS-2 (second international study of infarct survival) collaborative group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction ; ISIS-2. Lancet 1988 ; 2 : 349-360.
 
4) Fuster V, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992 ; 326 : 242-250.
PubMed
5) Ogawa H, Kojima S. Modern state of acute myocardial infarction in the interventional era : Observational case-control study-Japanese acute coronary syndrome study (JACSS). J Cardiol 2009 ; 54 : 1-9.
PubMed
6) Thygese K, et al. Universal definition of myocardial infarction. Circulation 2007 ; 116 : 2634-2653.
 
7) Yasue H, et al. Coronary artery spasm : Clinical features, diagnosis, pathogenesis, and treatment. J Cardiol 2008 ; 51 : 2-17.
PubMed
8) Miyao Y, et al. Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J 1993 ; 126 : 1299-1304.
PubMed
P.14 掲載の参考文献
1) Fuster V, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992 ; 326 : 242-250.
PubMed
2) Maseri A, Fuster V. Is there a vulnerable plaque? Circulation 2003 ; 107 : 2068-2071.
 
3) Yano K, et al. A comparison of the 12-year mortality and predictive factors of coronary heart disease among Japanese men in Japan and Hawaii. Am J Epidemiol 1988 ; 127 : 476-487.
 
4) Menotti A, et al. Twenty-five-year coronary mortality trends in the seven countries study using the accelerated failure time model. Eur J Epidemiol 2003 ; 18 : 113-122.
PubMed
5) Kubo M, et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community : The Hisayama study. Stroke 2003 ; 34 : 2349-2354.
 
6) Yusuf S. Preventing vascular events due to elevated blood pressure. Circulation 2006 ; 113 : 2166-2168.
PubMed
7) Haffner SM, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998 ; 339 : 229-234.
PubMed
8) Pristipino C, et al. Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction. Circulation 2000 ; 101 : 1102-1108.
PubMed
9) Eagle KA, et al. Practice variation and missed opportunities for reperfusion in ST-segmentelevation myocardial infarction : Findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002 ; 359 : 373-377.
 
10) Kaul P, et al. Long-term mortality of patients with acute myocardial infarction in the United States and Canada : Comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) -I. Circulation 2004 ; 110 : 1754-1760.
 
11) Fox KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007 ; 297 : 1892-1900.
PubMed
12) Jeger RV, et al. Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med 2008 ; 149 : 618-626.
PubMed
13) Ishihara M, et al. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J 2005 ; 150 : 814-820.
PubMed
14) Kasanuki H, et al. A large-scale prospective cohort study on the current status of therapeutic modalities for acute myocardial infarction in Japan : Rationale and initial results of the HIJAMI Registry. Am Heart J 2005 ; 150 : 411-418.
PubMed
15) Shiga T, et al. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era : Results from the HIJAMI-II registry. Heart 2009 ; 95 : 216-220.
PubMed
16) Rogers WJ, et al. Temporal trends in the treatment of over 1. 5 million patients with myocardial infarction in the US from 1990 through 1999 : The National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 2000 ; 36 : 2056-2063.
 
17) Okazaki S, et al. Early statin treatment in patients with acute coronary syndrome : Demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event : The ESTABLISH Study. Circulation 2004 ; 110 : 1061-1068.
PubMed
18) Sakamoto T, et al. Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese. Am J Cardiol 2006 ; 97 : 1165-1171.
PubMed
19) Nagashima M, et al. Effect of early statin treatment at standard doses on long-term clinical outcomes in patients with acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology Statin Evaluation Program). Am J Cardiol 2007 ; 99 : 1523-1528.
PubMed
P.20 掲載の参考文献
1) Shah PK. Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 2003 ; 41 : 15S-22S.
PubMed
2) 池田康夫 (監). 血栓症-やさしく・くわしく・わかりやすく. 東京 : 南江堂 ; 2004.
 
3) Virmani R, et al. Pathology of vulnerable plaque. J Am Coll Cardiol 2006 ; 47 : C13-18.
PubMed
P.21 掲載の参考文献
1) Virmani R, et al. Lessons from sudden coronary death : A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000 ; 20 : 1262-1275.
 
2) Virmani R, et al. Atherosclerotic plaque progression and vulnerability to rupture : Angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005 ; 25 : 2054-2061.
PubMed
3) Nakashima Y, et al. Early human atherosclerosis : Accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol 2007 ; 27 : 1159-1165.
PubMed
4) Mackman N, et al. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 2007 ; 27 : 1687-1693.
PubMed
P.26 掲載の参考文献
1) Fuster V, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992 ; 326 : 242-250.
PubMed
2) Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995 ; 91 : 2844-2850.
PubMed
3) van der Wal AC, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994 ; 89 : 36-44.
PubMed
4) Virmani R, et al. Lessons from sudden coronary death : A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000 ; 20 : 1262-1275.
 
5) Kovanen PT, et al. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995 ; 92 : 1084-1088.
PubMed
6) Naruko T, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002 ; 106 : 2894-2900.
PubMed
7) Libby P. Inflammation in atherosclerosis. Nature 2002 ; 420 : 868-874.
PubMed
8) Yilmaz A, et al. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 2004 ; 176 : 101-110.
PubMed
9) Kaikita K, et al. Tissue factor expression on macrophages in coronary plaques in patients with unstable angina. Arterioscler Thromb Vasc Biol 1997 ; 17 : 2232-2237.
PubMed
10) Soejima H, et al. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. Circulation 1999 ; 99 : 2908-2913.
PubMed
11) Sakamoto T, et al. Association of patency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction. Am J Cardiol 1992 ; 70 : 271-276.
PubMed
12) Nakayama M, et al. T-786 → C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999 ; 99 : 2864-2870.
 
P.32 掲載の参考文献
1) Braunwald's Heart Disease : A textbook of cardiovascular medicine, 8th edition, Philadelphia : Elsevier Saunders ; 2008. pp. 1195-1351.
 
1) ACC/AHA 2007 guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction : A report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2007 ; 50 : 1-157.
 
2) The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined : A consensus document of the joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000 ; 36 : 959-969.
 
3) Rogers WJ, et al. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990-2006. Am Heart J 2008 ; 156 : 1026-1034.
 
4) Sgarbossa EB, et al. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presense of left bundle-branch block. N Engl J Med 1996 ; 334 : 481-487.
 

2章 急性冠症候群を見逃さない

P.48 掲載の参考文献
1) Ryan TJ, et al. 1999 update : ACC/AHA guidelines for the management of patients with acute myocardial infarction : Executive summary and recommendations : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation 1999 ; 100 : 1016-1030.
 
2) Braunwald E, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction ; Summary article : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Unstable Angina). Circulation 2002 ; 106 : 1893-1900.
 
3) 平成11年度厚生科学研究費補助金 (医療技術評価総合研究事業) 「急性心筋梗塞およびその他の虚血性心疾患の診療情報の整理に関する研究」EBMに基づく急性心筋梗塞診療ガイドライン. 上松瀬勝男 (編), 急性心筋梗塞の診療エビデンス集-EBMより作成したガイドライン. 東京 : じほう出版 ; 2001.
 
4) 循環器病の診断と治療に関するガイドライン (2006-2007年度合同研究班報告, 班長 高野照夫) 急性心筋梗塞 (ST上昇型) の診療に関するガイドライン (JCS 2008). Circ J 2008 ; 72 (Suppl IV) : 1347-1442.
 
5) 循環器病の診断と治療に関するガイドライン (2000-2001年度合同研究班報告, 班長 : 山口徹) 急性冠症候群の診療に関するガイドライン. Circ J 2002 ; 66 (Suppl IV) : 1123-1163.
 
6) 循環器病の診断と治療に関するガイドライン (2006-2007年度合同研究班報告, 班長 ; 山口徹) 急性冠症候群の診療に関するガイドライン (2007年改訂版) (JCS 2007). http://www.j-circ.or.jp/guideline/index.htm (2009年3月).
 
P.53 掲載の参考文献
1) Pope JH, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000 ; 342 : 1163-1170.
PubMed
2) Lee TH, Goldman L. Evaluation of the patient with acute chest pain. N Engl J Med 2000 ; 343 : 584-585.
 
3) Cannon CP, Lee TH. Approach to the patient with chest pain. In : Braunwald's Heart Disease : A Textbook of Cardiovascular Medicine, 8th edition. Philadelphia : Elsevier Saunders ; 2008. pp. 1195-1205.
 
P.61 掲載の参考文献
1) Kosuge M, et al. Diff erentiation between acute pulmonary embolism and acute coronary syndromes on the basis of negative T waves. Am J Cardiol 2007 ; 99 : 817-821.
 
2) Agarwal JB, et al. Importance of posterior chest leads in patients with suspected myocardial infarction, but nondiagnostic, routine 12-lead electrocardiogram. Am J Cardiol 1999 ; 83 : 323-326.
PubMed
3) Menown IB, et al. Improving the ECG classifi cation of inferior and lateral myocardial infarction by inversion of lead aVR. Heart 2000 ; 83 : 657-660.
 
4) Yamaji H, et al. Prediction of acute left main coronary artery obstruction by 12-lead electrocardiography : ST segment elevation in lead aVR with less ST segment elevation in lead V (1). J Am Coll Cardiol 2001 ; 38 : 1348-1354.
PubMed
5) Engelen DJ, et al. Value of the electrocardiogram in localizing the occlusion site in the left anterior descending coronary artery in acute anterior myocardial infarction. J Am Coll Cardiol 1999 ; 34 : 389-395.
PubMed
P.72 掲載の参考文献
1) 清野精彦 (編著). 心筋梗塞と心筋・血管マーカー. 東京 : メジカルビュー社 ; 2002.
 
2) Vasan RS. Biomarkers of cardiovascular disease : Molecular basis and practical considerations. Circulation 2006 ; 113 : 2335-2362.
PubMed
3) 清野精彦, 高野照夫. 心筋生化学マーカーによる評価 : Multimarker strategy. 日内会誌 2004 ; 93 : 241-248.
 
4) 清野精彦ほか. 循環器診療における心筋トロポニンT迅速判定法の有用性に関する検討 : 東京地区循環器実地診療における評価-Tokyo Troponin T Trial (4T). J Cardiol 1998 ; 31 : 281-287.
 
5) Seino Y, et al. Pathophysiological analysis of troponin T release kinetics in evolving ischemic myocardial injury. Jpn Circ J 1996 ; 60 : 265-276.
PubMed
6) Seino Y, et al. Early identification of cardiac events with serum troponin T in patients with unstable angina. Lancet 1993 ; 342 : 1236-1237.
PubMed
7) Okamatsu K, et al. Elevated troponin T levels and lesion characteristics in non-ST-elevation acute coronary syndrome. Circulation 2004 ; 109 : 465-470.
PubMed
8) Ogawa A, et al. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation versus non-ST elevation acute coronary syndrome. Circ J 2006 ; 70 : 1372-1378.
 
9) Seino Y, et al. Use of whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain : Comparison with rapid troponin T and myoglobin tests. Am J Med 2003 ; 115 : 185-190.
PubMed
10) Fukushima M, et al. Dual-isotope myocardial SPECT in patients with redefined myocardial infarction. Int J Cardiol 2005 ; 104 : 204-212.
PubMed
11) Omland T, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation. 1996 ; 93 : 1963-1969.
PubMed
12) Richards AM, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin. Circulation 1998 ; 97 : 1921-1929.
PubMed
13) de Lemos JA, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Eng J Med 2001 ; 345 : 1014-1021.
 
14) Omland T, et al. N-termnal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002 ; 106 : 2913-2918.
 
15) 村上大介, 清野精彦. 急性冠症候群に対するバイオマーカー・ストラテジー. 医学のあゆみ 2008 ; 224 : 313-317.
Medical*Online
16) ACC/AHA Task Force. ACC/AHA guideline for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 2000 ; 36 : 970-1061.
PubMed
17) Thygesen K, et al. Universal definition of myocardial infarction. Eur Heart J 2007 ; 28 : 2525-2538.
PubMed
P.81 掲載の参考文献
1) Lang RM, et al. Recommendations for chamber quantification : A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005 ; 12 : 1440-1463.
 
2) Hozumi T, et al. Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography. Circulation 1998 ; 97 : 1557-1562.
PubMed
3) Tokai K, et al. Noninvasive assessment of myocardial ischemia in the left ventricular inferior regions by coronary flow reserve measurement using transthoracic Doppler echocardiography. J Am Soc Echocardiogr 2003 ; 12 : 1252-1257.
PubMed
4) Fujimoto K, et al. New noninvasive diagnosis of myocardial ischemia of the left circumflex coronary artery using coronary flow reserve measurement by transthoracic Doppler echocardiography : Comparison with thallium-201 single photon emission computed tomography. J Cardiol 2004 ; 43 : 109-116.
PubMed
5) Lee S, et al. Noninvasive evaluation of coronary reperfusion by transthoracic Doppler echocardiography in patients with anterior acute myocardial infarction before coronary intervention. Circulation 2003 ; 108 : 2763-2768.
PubMed
6) Hirata K, et al. Simple detection of occluded coronary artery using retrograde flow in septal branch and left anterior descending coronary artery by transthoracic Doppler echocardiography at rest. J Am Soc Echocardiogr 2004 ; 17 : 108-113.
 
7) Higashiue S, et al. Simple detection of severe coronary stenosis using transthoracic Doppler echocardiography at rest. Am J Cardiol 2001 ; 87 : 1064-1068.
PubMed
8) Hozumi T, et al. Value of acceleration flow and the prestenotic to stenotic coronary flow velocity ratio by transthoracic color Doppler echocardiography in noninvasive diagnosis of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 2000 ; 35 : 164-168.
PubMed
9) Ishii K, et al. Detection of postischemic regional left ventricular delayed outward wall motion or diastolic stunning after exercise-induced ischemia in patients with stable effort angina by using color kinesis. J Am Soc Echocardiogr 2008 ; 21 : 309-314.
PubMed
P.87 掲載の参考文献
1) Mochida Y. Estimation of the length of coronary thrombi and prediction of the result of coronary thrombolytic therapy based on the angiographic findings. J Cardiol 1996 ; 28 : 249-255.
PubMed
2) Ishihara M, et al. Acute myocardial infarction with patent infarctrelated artery : Selection of treatment based on qualitative analysis of coronary angiograms during the acute phase. J Cardiol 1990 ; 20 : 55-62.
PubMed
3) 上松瀬勝男 (編). EBM に基づく急性心筋梗塞診療ガイドライン. 東京 : じほう ; 2002.
 
4) Ambrose JA, et al. Angiographic morphology and the pathogenesis of unstable angina pectoris. JACC 1985 ; 5 : 609-616.
PubMed
P.94 掲載の参考文献
1) Wei K, et al. Comparison of usefulness of dipyridamole-stress myocardial contrast echocardiography to technetium-99m sestamibi single-photon emission computed tomography for detection of coronary artery disease (PB127 multicenter phase-2 trial results). Am J Cardiol 2003 ; 91 : 1293-1298.
PubMed
2) Peltier M, et al. Assessment of the physiologic significance of coronary disease with dipyridamole real-time myocardial contrast echocardiography. Comparison with technetium-99m sestamibi single-photon emission computed tomography and quantitative coronary angiography. J Am Coll Cardiol 2004 ; 43 : 257-264.
PubMed
3) Jayaweera AR, et al. Role of capillaries in determining coronary blood flow reserve : New insights using myocardial contrast echocardiography. Am J Physiol 1999 ; 277 : H2363-H2372.
PubMed
4) Wei K, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998 ; 97 : 473-483.
PubMed
P.102 掲載の参考文献
1) Naghavi M, et al. From vulnerable plaque to vulnerable patient : a call for new definitions and risk assessment strategies : Part I. Circulation 2003 ; 108 : 1664-1672.
 
2) Kawasaki M, et al. In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation 2002 ; 105 : 2487-2492.
PubMed
3) Nair A, et al. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002 ; 106 : 2200-2206.
PubMed
4) Wilson LS, et al. Preliminary results from attenuation-slope mapping of plaque using intravascular ultrasound. Ultrasound Med Biol 1994 ; 20 : 529-542.
PubMed
5) Hiro T, et al. Detection of fibrous cap in atherosclerotic plaque by intravascular ultrasound by use of color mapping of angle-dependent echo-intensity variation. Circulation 2001 ; 103 : 1206-1211.
PubMed
6) Murashige A, et al. Detection of lipid-laden atherosclerotic plaque by wavelet analysis of radio-frequency intravascular ultrasound signals : In vitro validation and preliminary in vivo application. J Am Coll Cardiol 2005 ; 45 : 1954-1960.
 
7) Hiro T, et al. Longitudinal visualization of spontaneous coronary plaque rupture by 3D intravascular ultrasound. Circulation 2000 ; 101 : E114-E115.
PubMed
8) Imoto K, et al. Longitudinal structural determinants of atherosclerotic plaque vulnerability : A computational analysis of stress distribution using vessel models and three-dimensional intravascular ultrasound imaging. J Am Coll Cardiol 2005 ; 46 : 1507-1515.
PubMed
9) Fukumoto Y, et al. Localized elevation of shear stress is related to coronary plaque rupture : A three-dimensional intravascular ultrasound study with in vivo color mapping of shear stress distribution. J Am Coll Cardiol 2008 ; 51 : 645-650.
 
P.109 掲載の参考文献
1) Virmani R, et al. Vulnerable plaque : The pathology of unstable coronary lesions. J Interv Cardiol 2002 ; 15 : 439-446.
PubMed
2) Yabushita H, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002 ; 106 : 1640-1645.
PubMed
3) Sawada T, et al. Feasibility of combined use of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for detecting thin-cap fibroatheroma. Eur Heart J 2008 ; 29 : 1136-1146.
PubMed
4) Kume T, et al. Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J 2006 ; 152 : 755.e1-755.e4.
 
5) Tearney GJ, et al. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003 ; 107 : 113-119.
PubMed
6) Kume T, et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 2006 ; 97 : 1713-1717.
PubMed
7) Xu C, et al. Characterization of atherosclerosis plaques by measuring both backscattering and attenuation coefficients in optical coherence tomography. J Biomed Opt 2008 ; 13 : 1-8.
PubMed
8) Jang IK, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005 ; 111 : 1551-1555.
PubMed
9) Kubo T, et al. Assessment of culprit lesion morphology in acute myocardial infarction. J Am Coll Cardiol 2007 ; 50 : 933--939.
 
10) Tanaka A, et al. Distribution and frequency of thin-capped fibroatheromas and ruptured plaques in the entire culprit coronary artery in patients with acute coronary syndrome as determined by optical coherence tomography. Am J Cardiol 2008 ; 102 : 975-979.
PubMed
11) Tanaka A, et al. Morphology of exertion-triggered plaque rupture in patients with acute coronary syndrome, an optical coherence tomography study. Circulation 2008 ; 118 : 2368-2373.
PubMed
P.119 掲載の参考文献
1) Ueda Y, et al. Neointimal coverage of stents in human coronary arteries observed by angioscopy. J Am Coll Cardiol 1994 ; 23 : 341-346.
PubMed
1) Asakura M, et al. Extensive development of vulnerable plaques as a pan-coronary process in the patients with myocardial infarction : Angioscopic study. J Am Coll Cardiol 2001 ; 37 : 1284-1288.
 
2) Ueda Y, et al. Healing process of infarct-related plaques : Insights from 18 months serial angioscopic follow-up. J Am Coll Cardiol 2001 ; 38 : 1916-1922.
PubMed
2) Ueda Y, et al. Elastic recoil and intimal thickening after coronary stenting. J Interven Cardiol 1995 ; 8 : 137-141.
 
3) Ueda Y, et al. Assessment of plaque vulnerability by angioscopic classification of plaque color. Am Heart J 2004 ; 148 : 333-335.
PubMed
3) Ueda Y, et al. Intracoronary morphology of culprit lesions after reperfusion in acute myocardial infarction : Serial angioscopic observations. J Am Coll Cardiol 1996 ; 27 : 606-610.
PubMed
4) Asakura M, et al. Remodeling of in-stent neointima, which became thinner and transparent over 3 years : Serial angioscopic and angiographic follow-up. Circulation 1998 ; 97 : 2003-2006.
PubMed
4) Ohtani T, et al. Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome : Detection of vulnerable patients by angioscopy. J Am Coll Cardiol 2006 ; 47 : 2194-2200.
 
5) Ueda Y, et al. Plaque characterization and atherosclerosis evaluation by coronary angioscopy. Herz 2003 ; 28 : 501-504.
PubMed
5) Adachi T, et al. Angioscopic observation after coronary angioplasty for chronic coronary occlusion comparison with severe stenotic lesion. Diagnostic and Therapeutic Endoscopy 2000 ; 7 : 7-14.
PubMed
6) Ueda Y, et al. Color of culprit lesion at 6 months after POBA vs. stenting in patients with acute myocardial infarction. Am Heart J 2004 ; 148 : 842-846.
PubMed
7) Ohtani T, et al. Association between cardiac troponin T elevation and angioscopic morphology of culprit lesion in patients with non-ST-segment elevation acute coronary syndrome. Am Heart J 2005 : 150 : 227-233.
PubMed
8) Komatsu S, et al. Detection of coronary plaque by computed tomography with a novel plaque analysis system, 'Plaque Map', and comparison with intravascular ultrasound and angioscopy. Circ J 2005 ; 69 : 72-77.
PubMed
9) Mizote I, et al. Distal protection improved reperfusion and reduced left ventricular dysfunction in patients with acute myocardial infarction who had angioscopically-defined ruptured plaque. Circulation 2005 ; 112 : 1001-1007.
PubMed
10) Okuyama Y, et al. Coronary angioscopy revealing ruptured plaque and thrombus causing acute anterior myocardial infarction with a subsequent acute inferior myocardial infarction : A case report. International Journal of Angiology 2005 ; 14 : 34-36.
 
11) Ueda Y, et al. Angioscopically-determined extent of coronary atherosclerosis is associated with severity of acute coronary syndrome. J Invasive Cardiol 2006 ; 18 : 220-224.
PubMed
12) Oyabu J, et al. Angioscopic evaluation of neointima coverage : Sirolimus drug-eluting stent vs. bare metal stent. Am Heart J 2006 ; 152 : 1168-1174.
PubMed
13) Ueda Y, et al. Acute myocardial infarction without disrupted yellow plaque in young patients below 50 years old. J Interven Cardiol 2007 ; 20 : 177-181.
 
14) Okada K, et al. Plaque color analysis by conventional yellow-color grading system and quantitative measurement using LCH color space. J Interven Cardiol 2007 ; 20 : 324-334.
 
15) Ueda Y, et al. Angioscopy of culprit lesions. Cardiologla 1997 ; 42 : 827-832.
PubMed
16) Kodama K, et al. The role of plaque rupture in the development of acute coronary syndrome evaluated by the coronary angioscope. Intern Med 2000 ; 39 : 333-335.
PubMed
17) Ueda Y, et al. Coronary atherosclerosis and acute coronary syndrome : New insights from angioscopic viewpoints. Vascular Disease Prevention 2004 ; 1 : 53-57.
 
P.127 掲載の参考文献
1) 木原康樹, 伊藤亨 (編著). 冠動脈疾患とMDCT : 64列MDCTによる新たな診断の幕開け. 東京 : 文光堂 ; 2006, pp. 1-173.
 
2) Goldstein JA. Coronary plaque characterization by computed tomographic angiography : Present promise and future hope. JACC Cardiovasc Imaging 2009 ; 2 : 161-163.
PubMed
3) Kitagawa T, et al. Comprehensive evaluation of noncalcified coronary plaque characteristics detected using 64-slice computed tomography in patients with proven or suspected coronary artery disease. Am Heart J 2007 ; 154 : 1191-1198.
PubMed
4) Kitagawa T, et al. Characterization of noncalcified coronary plaques and identification of culprit lesions in patients with acute coronary syndrome by 64-slice computed tomography. JACC Cardiovasc Imaging 2009 ; 2 : 153-160.
PubMed
5) Detrano R, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008 ; 358 : 1336-1345.
PubMed
P.133 掲載の参考文献
1) Kontos MC, et al. Comparison of myocardial perfusion imaging and cardiac troponin I in patients admitted to the emergency department with chest pain. Circulation 1999 ; 99 : 2073-2078.
 
2) Hilton TC, et al. Technetium-99m sestamibi myocardial perfusion imaging in the emergency room evaluation of chest pain. J Am Coll Cardiol 1994 ; 23 : 1016-1022.
PubMed
3) Udelson JE, et al. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia : A randomized controlled trial. JAMA 2002 ; 288 : 2693-2700.
PubMed
4) Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging in patients with unstable angina who respond to medical treatment. J Am Coll Cardiol 1991 ; 17 : 1053-1057.
PubMed
5) Gill JB, et al. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med 1987 ; 317 : 1486-1489.
 
6) Cerqueira MD, et al. Long-term survival in 618 patients from the Western Washington Streptokinase in Myocardial Infarction trials. J Am Coll Cardiol 1992 ; 20 : 1452-1459.
PubMed
7) Mahmarian JJ, et al. A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarction. J Am Coll Cardiol 2006 ; 48 : 2448-2457.
 
8) Germano G, Berman DS. Clinical Gated Cardiac SPECT. 2nd edition, Blackwell Publishing ; 2006 ; pp. 93-137.
 

3章 急性冠症候群のベストの急性期治療は何か

P.143 掲載の参考文献
1) 野々木宏. 虚血性心疾患の発生率と医療対策へのモニタリング方法の確立と国際比較に関する研究. 11公-6 平成11年度厚生省循環器病研究委託費による研究報告要旨. 2000, pp. 288-295.
 
2) 東海林哲郎ほか. 成人内因性搬入時心肺停止症例における急性心筋梗塞の頻度とその超急性期突然死例の病態 : 剖検時冠動脈造影と病理組織学的検討. 日本救急医学雑誌 1998 ; 9 : 143-157.
 
3) Iwami T, et al. Effectiveness of bystander-initiated cardiac-only resuscitation for patients with out-of-hospital cardiac arrest. Circulation 2007 ; 116 : 2900-2907.
PubMed
4) American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2005 ; 112 (suppl I) : IV-1-IV-203.
PubMed
5) Antman EM, et al. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction : A report of the American College of Cardiology/American Heart Association task force on practice guidelines : Developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians : 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee. Circulation 2008 ; 117 : 296-329.
 
6) Ting HH, et al. Implementation and integration of prehospital ECGs into systems of care for acute coronary syndrome : A scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursing, and Council on Clinical Cardiology. Circulation 2008 ; 118 : 1066-1079.
PubMed
7) Otsuka Y, et al. Novel mobile telemedicine system for real-time transmission of out-of-hospital ECG data for ST-elevation myocardial infarction. Catheter Cardiovasc Interv 2009 (in press).
 
P.149 掲載の参考文献
1) Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction : Is timing (almost) everything? Am J Cardiol 2003 ; 92 : 824-826.
PubMed
2) De Luca G, et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction : Every minute of delay counts. Circulation 2004 ; 109 : 1223-1225.
PubMed
3) Anderson HR, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003 ; 349 : 733-742.
 
4) White HD, et al. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarctions complicated by cardiogenic shock : Results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation 2005 ; 112 : 1992-2001.
PubMed
5) Steg PG, et al. Mortality following placement of drug-elluting and bare-metal stents for STsegment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. Eur Heart J 2009 ; 30 : 321-329.
PubMed
6) Daeme J, et al. Comaprison of three-year clinical outcome of sirolimus-and paclitaxel-eluting stent versus bare metal stents in patients with ST-segment elevation myocardial infarction(from the RESEARCH and T-SEARCH Registries). Am J Cardiol 2007 ; 99 : 1027-1032.
 
7) Shishehbor MH, et al. Comparison of drug-eluting stents versus bare-metal stents for treating ST-segment elevation myocardial infarction. J Am Coll Cardiol Intv 2008 ; 1 : 227-232.
 
8) Kastrati K, et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 2007 ; 28 : 2706-2713.
 
9) Mauri L, et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 2008 ; 359 : 1330-1342.
 
P.159 掲載の参考文献
1) Mehta SR, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention : The PCI-CURE study. Lancet 2001 ; 358 : 527-533.
PubMed
2) Steinhuble SR, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention : A randomized controlled trial. JAMA 2002 ; 288 : 2411-2420.
 
3) Montalescot G, et al. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes : The ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) Trial. J Am Coll Cardiol 2006 ; 48 : 931-938.
 
4) Fox KAA, et al. for the GRACE Investigators. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007 ; 297 : 1892-1900.
PubMed
P.169 掲載の参考文献
1) Antman EM, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction : Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2004 ; 44 : 671-719.
 
2) Ross AM, et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction : The PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial. J Am Coll Cardiol 1999 ; 34 : 1954-1962.
 
3) Zehender M, et al. Eligibility for and benefit of thrombolytic therapy in inferior myocardial infarction : Focus on the prognostic importance of right ventricular infarction. J Am Coll Cardiol 1994 ; 24 : 362-369.
PubMed
4) Antman EM, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. J Am Coll Cardiol 2008 ; 51 : 210-247.
PubMed
5) Van de Werf F, et al. Management of acute myocardial infarction in patients presenting with persistent ST-elevation. Eur Heart J 2008 ; 29 : 2909-2945.
PubMed
P.178 掲載の参考文献
1) Bavry AA, et al. Benefit of early invasive therapy in acute coronary syndromes : A metaanalysis of contemporary randomized clinical trials : J Am Coll Cardiol 2006 ; 48 : 1319-1325.
PubMed
2) Keeley EC, et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review of 23 randomised trials. Lancet 2003 ; 361 : 13-20.
PubMed
3) Nakagawa Y, et al. Serial angiographic follow-up after successful direct angioplasty for acute myocardial infarction. Am J Cardiol 1996 ; 78 : 980-984.
PubMed
4) Grines CL, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999 ; 341 : 1949-1956.
 
5) Spaulding C, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006 ; 355 : 1093-1104.
PubMed
6) Kimura T, et al : Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 2009 ; 119 : 987-995.
PubMed
P.186 掲載の参考文献
1) Falk E, et al. Coronary plaque disruption. Circulation 1995 ; 92 : 657.
PubMed
2) Gibson CM, et al ; TIMI Study Group. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 2002 ; 105 : 1909-1913.
 
3) Stone GW, et al. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am coll Cardiol 2002 ; 39 : 591-597.
PubMed
4) Grines CL, et al. Coronary angioplasty with or without stent implantation for acute myo-cardial infarction. N Engl J Med 1999 ; 341 : 1949-1956.
 
5) Stone GW, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002 ; 346 : 957-966.
 
6) Gibson CM, et al. Relationship of TIMI myocardial perfusion grade to mortality afteer administration of thrombolytic drugs. Circulation 2000 ; 101 : 125-130.
 
7) Kaplan BM, et al. Prospective study of extraction atherectomy in patients with acute myocardial infarction. Am J Cardiol 1996 ; 78 : 383-388.
PubMed
8) Stone GW, et al. Prospective, randomised evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries. J Am Coll Cardiol 2003 ; 42 : 2007-2013.
PubMed
9) Vlaar PJ, et al. Cardiac death and reinfarction after 1 year in the thrombus aspiration during percutaneous coronary intervention in acute myocardial infarction study (TAPAS) : A 1-year follow-up study. Lancet 2008 ; 371 : 1915-1930.
 
10) Kotani J, et al. Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 2002 ; 106 : 1672-1677.
 
11) Prati F, et al. Stenting of culprit lesions in unstable angina leads to a marked reduction in plaque burden : A major role of plaque embolization? A serial intravascular ultrasound study. Circulation 2003 ; 107 : 2320-2325.
 
12) Kotani J, et al. Volumetric intravascular ultrasound evidence that distal embolization during acute myocardial infarction contributes to inadequate myocardial perfusion grade. Am J Cardiol 2003 ; 92 : 728-732.
 
13) Iakovou I, et al. Increased CK-MB release is a" trade off" for optimal stent implantation : An intravascular ultrasound study. J Am Coll Cardiol 2003 ; 42 : 1906-1908.
 
14) Ellis SG, et al. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. J Am Coll Cardiol 1998 ; 32 : 1619-1623.
PubMed
15) Baim DS, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002 ; 105 : 1285-1290.
PubMed
16) Stone GW, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction : A randomized controlled trial. JAMA 2005 ; 293 : 1063-1072.
PubMed
17) Lee SY, et al. Attenuated plaque detected by intravascular ultrasound : Clinical, angiographic, and morphologic features and post-percutaneous coronary intervention complications in patients with acute coronary syndrome. J Am Coll Cardiol Intv 2009 ; 2 : 65-72.
 
18) Piana RN, et al. Incidence and treatment of' no-reflow' after percutaneous coronary intervention. Circulation 1994 ; 89 : 2514-2518.
PubMed
19) Mehran R, et al. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions : Intravascular ultrasound study of 2256 patients. Circulation 2000 ; 101 : 604-610.
PubMed
20) Nakazawa G, et al. Efficacy of culprit plaque assessment by 64-slice multidetector computed tomography to predict transient no-reflow phenomenon during percutneous coronary intervention. Am Heart J 2008 ; 155 : 1150-1157.
 
21) Mizote I, et al. Distal protection improved reperfusion and reduced left ventricular dysfunction in patients with acute myocardial infarction who had angioscopically defined ruptured plaque. Circulation 2005 ; 112 : 1001-1007.
PubMed
22) Tanaka A, et al. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation 2002 ; 105 : 2148-2152.
PubMed
23) Kotani J, et al. Usefulness of preprocedural coronary lesion morphology as assessed by intravascular ultrasound in predicting thrombolysis in myocardial infarction frame count after percutaneous coronary intervention in patients with Q-wave acute myocardial infarction. Am J Cardiol 2003 ; 91 : 870-872.
PubMed
P.193 掲載の参考文献
1) Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007 ; 357 : 1121-1135.
PubMed
2) Ishihara M, et al. Implications of prodromal angina pectoris in anterior wall acute myocardial infarction. Acute angiographic findings and long-term prognosis. J Am Coll Cardiol 1997 ; 30 : 970-975.
PubMed
3) Ishii H, et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment elevation myocardial infarction. Circulation 2005 ; 112 : 1284-1288.
PubMed
4) Kitakaze M, et al. The J-WIND investigators. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND) : Two randomized trials. Lancet 2007 ; 370 : 1483-1493.
 
5) Ishii H, et al. Pharmacological intervention for prevention of left ventricular remodeling and improving prognosis in myocardial infarction. Circulation 2008 ; 118 : 2710-2718.
PubMed
P.201 掲載の参考文献
1) Gersh BJ, et al. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction : Is the slope of the curve the shape of the future? JAMA 2005 ; 293 : 979-986.
PubMed
2) Ishihara M, et al. Effect of prodromal angina pectoris on altering relation between time to reperfusion and outcomes after a first anterior wall acute myocardial infarction. Am J Cardiol 2003 ; 91 : 128-132.
PubMed
3) Hirayama A, et al. Late reperfusion for acute myocardial infarction limits the dilatation of left ventricle without the reduction of infarct size. Circulation 1993 ; 88 : 2565-2574.
PubMed
4) Horie H, et al. Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty. Circulation 1998 ; 98 : 2377-2382.
PubMed
5) Hochman JS, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 2006 ; 355 : 2395-2407.
PubMed
P.212 掲載の参考文献
1) Hockman JS, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999 ; 341 : 625-634.
 
2) Menon V, Hochman JS. Management of cardiogenic shock complicating acute myocardial infarction. Heart 2002 ; 88 : 531-537.
PubMed
3) Hockman JS, et al. One-year survival following early revascularization for cardiogenic shock. JAMA 2001 ; 285 : 190-192.
 
4) Hochman JS. Caridogenic shock complicating acute myocardial infarction : Expanding the paradigm. Circulation 2003 ; 107 : 2998-3002.
 
5) Cotter G, et al. LINCS : L-NAME (a NO synthase inhibitor) in the treatmentof refractory cardiogenic shock : A prospective randomized study. Eur Heart J 2003 ; 24 : 1287-1295.
 
P.219 掲載の参考文献
1) Manesh R, et al. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization. A report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology. Circulation 2009 : published online Jan 8, 2009.
 
2) ACC/AHA 2004 guideline update for coronary artery bypass graft surgery. Circulation 2004 ; 110 ; e340-e437.
PubMed
3) Creswell LL, et al. Revascularization after acute myocardial infarction. Ann Thorac Surg 1995 ; 60 : 19-26.
 
4) Calvin JE. Optimal right ventricular filling pressures and the role of pericardial constraint in right ventricular infarction in dogs. Circulation 1991 ; 84 : 852-861.
PubMed
5) Goldstein JA, et al. Importance of left ventricular function and systolic ventricular interaction to right ventricular performance during acute right heart ischemia. J Am Coll Cardiol 1992 ; 19 : 704-711.
 
6) Yusuf S, et al. for the Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001 ; 345 : 494-502.
PubMed
7) Kim JH-J, et al. Clopidogrel use and bleeding after coronary artery bypass graft surgery. Am Heart J 2008 ; 156 : 886-892.
PubMed
8) Christenson JT, et al. Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients. Ann Thorac Surg 1999 ; 68 : 934-939.
PubMed
9) Christakis GT, et al. Reducing the risk of urgent revascularization for unstable angina : A randomized clinical trial. J Vasc Surg 1986 ; 3 : 764-772.
PubMed
10) Serruys PW, et al. the SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009 ; 360 : 961-972.
PubMed
P.228 掲載の参考文献
1) McNamara RL, et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2006 ; 47 : 2180-2186.
PubMed
2) 竹島啓子ほか. 急性心筋梗塞症におけるdoor-to-balloon time短縮の取り組み. 冠疾患誌 2006 ; 12 (abstract) : 372.
 
3) ACC/AHA Guidelines for the management of patients with ST-elevation myocardial infarction (2004). Circulation 2004 ; 110 : 82-292.
 
4) 日本腎臓学会 (編). CKD診療ガイド. 東京 ; 東京医学社 ; 2007. pp. 80-81.
 
P.237 掲載の参考文献
1) 副島秀久ほか. 医療記録が変わる! 決定版クリニカルパス. 東京 : 医学書院 ; 2004
 
2) 副島秀久ほか. 変化の時代に対応するクリニカルパス. 東京 : 照林社 ; 2007 ; pp. 40-45.
 
3) 松田宏史ほか. クリニカルパスの手法を用いた, アウトカム-バリアンス管理のための新しいソフトウエアの開発. 循環器専門医 2008 ; 16 : 311-317.
 

4章 急性冠症候群の再発をいかに防ぐか

P.245 掲載の参考文献
1) Yasue H, et al. Japanese Antiplatelets Myocardial Infarction Study (JAMIS) Investigators. Comparison of the effects of alternate-day aspirin 81 mg and daily aspirin 162 mg on inhospital cardiovascular events after myocardial infarction : An open-label, controlled, randomized clinical trial. Am Heart J 2000 ; 139 : e10-e15.
 
2) Ueshima K, et al. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study. Am Heart J 2004 ; 148 : e8.
 
3) Dormandy J, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (prospective pioglitazone clinical trial in macrovascular events) : A randomised controlled trial. Lancet 2005 ; 366 : 1279-1289.
PubMed
4) Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein H. et al. The action to control cardiovascular risk in diabetes study group : Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008 ; 358 : 2545-2559.
 
5) ADVANCE Collaborative Group, Patel A, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008 ; 358 : 2560-2572.
 
6) Duckworth W, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2008 ; 360 : 129-139.
PubMed
7) Jay S, et al. Intensive glycemic control and the prevention of cardiovascular events : Implications of the ACCORD, ADVANCE, and VA Diabetes Trials. A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 2009 ; 32 : 187-192.
 
P.251 掲載の参考文献
1) Fuster V, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1) & (2). N Engl J Med 1992 ; 326 : 242-250 & 310-318.
 
2) Sakamoto T, et al. Association of patency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction. Am J Cardiol 1992 ; 70 : 271-276.
PubMed
3) Miyamoto S, et al. Increased rate of formation of small-sized platelet aggregates in patients with acute coronary syndromes. Jpn Circ J 2000 ; 64 : 647-652.
PubMed
4) Miyamoto Y, et al. Formation of platelet microaggregates correlates with adverse clinical outcome inpatients with coronary artery disease. Thromb Haemost 2003 ; 89 : 681-686.
 
5) Ebbeling L, et al. Rapid ultrastructural changes in the dense tubular system following platelet activation. Blood 1992 ; 80 : 718-723.
PubMed
6) Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002 ; 324 : 71-86.
PubMed
7) Kimura T, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 2009 ; 119 : 987-995.
PubMed
8) Yasue H, et al. Effects of aspirin and trapidil on cardiovascular events after acute myocardial infarction. Am J Cardiol 1999 ; 83 : 1308-1313.
PubMed
9) Yasue H, et al. Comparison of the effects of alternate-day aspirin 81 mg and daily aspirin 162 mg on in-hospital cardiovascular events after myocardial infarction : An open-label, controlled, randomized clinical trial. Am Heart J 2000 ; 139 : e10-e15.
 
P.259 掲載の参考文献
1) Munzel T, et al. New insights into mechanisms underlying nitrate tolerance. Am J Cardiol 1996 ; 77 : 24C-30C.
PubMed
2) Sydow K, et al. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest 2004 ; 113 : 482-489.
PubMed
3) Ishikawa K, et al. Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Secondary Prevention Group. Jpn Circ J 1996 ; 60 : 779-788.
PubMed
4) ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4 : A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995 ; 345 : 669-685.
 
5) Ishii H, et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 2005 ; 112 : 1284-1288.
PubMed
P.265 掲載の参考文献
1) 百村伸一ほか. 冠動脈インターベンション後の血圧管理. 血圧 2007 ; 8 : 789-792.
Medical*Online
2) 平田浩三ほか. β遮断薬/α遮断薬. 綜合臨牀 2007 ; 56 : 2675-2681.
Medical*Online
3) 藤本陽ほか. β遮断薬. 腎と透析 2004 ; 287-289.
 
4) Randomised trial of intravenous atenolol among 16,207 cases of suspected actue myocardial infarction : ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 1986 ; 2 : 57-66.
 
5) Doughty RN, et al. CAPRICORN Echo Substudy Investigators. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction : The CAPRICON Echo Substudy. Circulation 2004 ; 109 : 201-206.
 
6) Japanese beta-Blockers and Calcium Antagonists Myocardial Infarction (JBCMI) Investigators. Comparison of the effects of beta blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese subjects. Am J Cardiolol 2004 ; 93 : 969-973.
 
7) Yusuf S, et al. Beta blockade during and after myocardial infarction : An overview of the randomized trials. Prog Cardiovasc Dis 1985 ; 27 : 335-371.
PubMed
8) Yusuf, et al. Overview of results of randomized clinical trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 1988 ; 260 : 2259-2263.
PubMed
9) Dargie HJ ; CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infaction in patients with left ventricular dysfunction : The CAPRICORN randomized trial. Lancet 2001 ; 357 : 1385-1390.
 
10) McMurray J, et al. Antiarrhythmic effect of carvedilol after acute myocardial infaction : Results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol 2005 ; 45 : 525-530.
 
11) Ryden L, et al. A double-blind trial of metoprolol in acute myocardial infarction : Effects on ventricular tachyarrhythmias. N Engl J Med 1983 ; 308 : 614-618.
 
P.273 掲載の参考文献
1) Ogawa H, et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes : A randomized controlled trial. JAMA 2008 ; 300 : 2134-2141.
PubMed
2) The Israeli Sprint Study Group. Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. Eur Heart J 1988 ; 9 : 354-364.
 
3) The Israeli Sprint Study Group. Early administration of nifedipine in suspected acute myocardial infarction the secondary prevention reinfarction Israel nifedipine trial 2 study. Arch Intern Med 1993 ; 153 : 345-353.
 
4) Goldstein RE, et al. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 1991 ; 83 : 52-60.
PubMed
5) The Danish study group on Verapamil in myocardial infarction. Verapamil in acute myocardial infarction. Eur Heart J 1984 ; 5 : 516-528.
 
6) The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II-DAVIT II). Am J Cardiol 1990 ; 66 : 779-785.
 
7) Poole-Wilson PA, et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patient with stable angina requiring treatment (ACTION trial) : Randomised controlled trial. Lancet 2004 ; 364 : 849-857.
PubMed
8) Steven E, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure : The CAMELOT study : A randomized controlled trial. JAMA 2004 ; 292 : 2217-2225.
 
9) The Japanese β-blockers and Calcium Antagonists Myocardial Infarction (JBCMI) Investigators. Comparison of the effects of beta blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese subjects. Am J Cardiol 2004 ; 93 : 969-973.
 
10) Julius S, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine : The VALUE randomised trial. Lancet 2004 ; 363 : 2022-2031.
 
P.279 掲載の参考文献
1) Cannon CP, et al. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004 ; 350 : 1495-1504.
 
2) Bavry AA, et al. Long-term benefit of statin therapy initiated during hospitalization for acute coronary syndrome. Am J Cardiovasc Drugs 2007 ; 7 : 135-141.
PubMed
3) Moghadasian MH. Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Life Sci 1999 ; 65 : 1329-1337.
PubMed
4) Berter P, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007 ; 357 : 1301-1310.
 
P.284 掲載の参考文献
1) Pfeffer MA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction : Results of the survival and ventricular enlargement trial : The SAVE Investigators. N Engl J Med 1992 ; 327 : 669-677.
 
2) Dickstein K, et al. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction : The OPTIMAAL randomised trial. Lancet 2002 ; 360 : 752-760.
PubMed
3) ONTARGET Investigators, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008 ; 358 : 1547-1559.
 
4) Julius S, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine : The VALUE randomised trial. Lancet 2004 ; 363 : 2022-2031.
 
5) Blood pressure lowering treatment trialists' collaboration, et al. Blood pressure-dependent and independent effects of agents that inhibit the rennin-angiotensin system. J Hypertens 2007 ; 25 : 951-958.
 
P.288 掲載の参考文献
1) Andersen HR, et al. for the DANAMI-2 investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003 ; 349 : 733-742.
 
2) Fernandez-Aviles F, et al. on behalf of the GRACIA (grupo de analisis de la cardiopatia isquemica aguda) group. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1) : A randomised controlled trial. Lancet 2004 ; 364 : 1045-1053.
 
P.293 掲載の参考文献
1) Eagle KA, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004, 110 : e340-437.
 
1) Kleisli T, et al. In the current era, complete revascularization improves survival after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2005 ; 129 : 1283-1291.
PubMed
2) Hannan EL, et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008 ; 358 : 331-341.
PubMed
2) Puskas J, et al. Off-pump versus conventional coronary artery bypass grafting : A meta-analysis and consensus statement from The 2004 ISMICS Consensus Conference. Innovations 2005 ; 1 : 3-27.
PubMed
3) Fukui T, et al. Early and midterm results of off-pump coronary artery bypass grafting. Ann Thorac Surg 2007 ; 83 : 115-119.
PubMed
3) Barner HB. Operative treatment of coronary atherosclerosis. Ann Thorac Surg 2008 ; 85 : 1473-1482.
PubMed
4) Lytle BW, et al. Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc Surg 1999 ; 117 : 855-872.
 
5) Takanashi S, et al. Coronary endarterectomy in the left anterior descending artery. J Cardiol 2008 ; 52 : 261-268.
PubMed
P.299 掲載の参考文献
1) Endo J, et al. Bone marrow derived cells are involved in the pathogenesis of cardiac hypertrophy in response to pressure overload. Circulation 2007 ; 116 : 1176-1184.
PubMed
2) Dib N, et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy : Four-year follow-up. Circulation 2005 ; 112 : 1748-1755.
PubMed
3) Kang HJ, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction : The MAGIC cell randomised clinical trial. Lancet 2004 ; 363 : 751-756.
PubMed
4) Asahara T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 ; 275 : 964-967.
PubMed
5) Shintani S, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001 ; 103 : 2776-2779.
PubMed
6) Wollert KC, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction : The BOOST randomised controlled clinical trial. Lancet 2004 ; 364 : 141-148.
PubMed
7) Janssens S, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction : Double-blind, randomised controlled trial. Lancet 2006 ; 367 : 113-121.
PubMed
8) Schachinger V, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006 ; 355 : 1210-1221.
PubMed
9) Erbs S, et al. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction : The Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial. Circulation 2007 ; 116 : 366-374.
PubMed
10) Schachinger V, et al. Improved clinical outcome after intracoronary administration of bonemarrow-derived progenitor cells in acute myocardial infarction : Final 1-year results of the REPAIR-AMI trial. Eur Heart J 2006 ; 27 : 2775-2783.
 
11) Lunde K, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006 ; 355 : 1199-1209.
PubMed
12) Hill JM, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003 ; 348 : 593-600.
PubMed
13) Kondo T, et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004 ; 24 : 1442-1447.
PubMed
14) Tatsumi T, et al. Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circ J 2007 ; 8 : 1199-1207.
PubMed
15) Ince H, et al. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 2005 ; 112 : 3097-3106.
PubMed
16) Zohlnhofer D, et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction : A randomized controlled trial. JAMA 2006 ; 295 : 1003-1010.
PubMed
17) Ripa RS, et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction : Result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 2006 ; 113 : 1983-1992.
PubMed
18) Kang HJ, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction : The MAGIC cell randomised clinical trial. Lancet 2004 ; 363 : 751-756.
PubMed

書評

最近チェックした商品履歴

Loading...